Graph convolutional networks for computational drug development and discovery

M Sun, S Zhao, C Gilvary, O Elemento… - Briefings in …, 2020 - academic.oup.com
Despite the fact that deep learning has achieved remarkable success in various domains
over the past decade, its application in molecular informatics and drug discovery is still …

Superparamagnetic iron oxide nanoparticle-based delivery systems for biotherapeutics

H Mok, M Zhang - Expert opinion on drug delivery, 2013 - Taylor & Francis
Introduction: Superparamagnetic iron oxide nanoparticle (SPION)-based carrier systems
have many advantages over other nanoparticle-based systems. They are biocompatible …

Adaptive graph convolutional neural networks

R Li, S Wang, F Zhu, J Huang - Proceedings of the AAAI conference on …, 2018 - ojs.aaai.org
Abstract Graph Convolutional Neural Networks (Graph CNNs) are generalizations of
classical CNNs to handle graph data such as molecular data, point could and social …

Traditional Chinese formula Xiaoyaosan alleviates depressive-like behavior in CUMS mice by regulating PEBP1-GPX4-mediated ferroptosis in the hippocampus

H Jiao, H Yang, Z Yan, J Chen, M Xu… - Neuropsychiatric …, 2021 - Taylor & Francis
Background At present, the pathogenesis of depression is not fully understood, and nearly
half of depression patients experience no obvious effects during treatment. This study aimed …

[HTML][HTML] Antidepressant mechanism of traditional Chinese medicine formula Xiaoyaosan in CUMS-induced depressed mouse model via RIPK1-RIPK3-MLKL …

ZY Yan, HY Jiao, JB Chen, KW Zhang… - Frontiers in …, 2021 - frontiersin.org
Background: Depression is a stress-related disorder that seriously threatens people's
physical and mental health. Xiaoyaosan is a classical traditional Chinese medicine formula …

[HTML][HTML] Correlation between nivolumab exposure and treatment outcomes in non–small-cell lung cancer

EA Basak, SLW Koolen, DP Hurkmans… - European Journal of …, 2019 - Elsevier
Introduction Nivolumab treatment is subject to large interpatient variability in both efficacy
and toxicity, which may partly be explained by differences in nivolumab exposure. Exposure …

Potential sources of inter-subject variability in monoclonal antibody pharmacokinetics

KL Gill, KK Machavaram, RH Rose, M Chetty - Clinical pharmacokinetics, 2016 - Springer
Understanding inter-subject variability in drug pharmacokinetics and pharmacodynamics is
important to ensure that all patients attain suitable drug exposure to achieve efficacy and …

Biologics: an update and challenge of their pharmacokinetics

S Shi - Current Drug Metabolism, 2014 - ingentaconnect.com
Biologics, including but not limited to monoclonal antibodies (mAbs), cytokines, growth
factors, enzymes, hormones, vaccines, antibody fragments (eg Fabs), and antibody drug …

Unraveling the effect of immunogenicity on the PK/PD, efficacy, and safety of therapeutic proteins

A Smith, H Manoli, S Jaw, K Frutoz… - Journal of …, 2016 - Wiley Online Library
Biologics have emerged as a powerful and diverse class of molecular and cell‐based
therapies that are capable of replacing enzymes, editing genomes, targeting tumors, and …

The pharmacological management of patients with comorbid psoriasis and obesity

A Chiricozzi, P Gisondi, G Girolomoni - Expert Opinion on …, 2019 - Taylor & Francis
Introduction: Psoriasis is a chronic inflammatory skin disease that is increasingly being
recognized as a complex disorder affecting multiple systems. Systemic inflammation is …